We describe a case with molecular duplication of chromosome 17 (pll.2-pl2) whose duplicated chromosome was inherited from a mosaic father. The 
CMT1A is the most common The finding that peripheral myelin protein 22 (PMP22) is contained within, but not disrupted by the duplication in CMT1A, and the fact that high levels of PMP22 mRNA have been detected only in the peripheral nervous system (the affected tissue in both CMT1A and HNPP), has led to the suggestion that gene dosage may underlie these disorders.'01' Molecular analysis of DNA markers at this critical region is the most common technique for diagnosis of duplication; however, in families not informative for these markers and in homozygous sporadic cases, a diagnosis is often difficult. Additionally, such methods would not detect the presence of a duplication in a mosaic patient. FISH analysis using probes within this region offers the potential to resolve these problems.
We report the first instance of mosaicism in CMT1A, where an affected proband has inherited the disease from a mildly affected mosaic father.
Materials and methods

SOUTHERN BLOT ANALYSIS
Genomic DNA was digested with the appropriate restriction enzymes and Southern blot was obtained as previously reported.'2 DNA probes VAW409R3A(D 17S 122) and p132G8RI(PMP-22) were labelled with 32P-dCTP using primer extension'3 and hybridised to the blot.
FISH ANALYSIS
Slides were prepared by standard cytogenetic protocols, and pretreated with RNase and pepsin to optimise the hybridisation. A YAC clone (49H7) which spans the smallest duplication region and includes the PMP22 gene and VAW409 was labelled with Biotin-16-dUTP (Boehringer) by a nick translation kit (Gibco BRL). After separation of the labelled probe using Sephadex G-50 spin column, 250 ng of the probe and 300 ng CotI DNA were added to a hybridisation mix consisting of 50% formamide, 20% dextran sulphate, and 2 x SSCP. The mixture was denatured at 80°C for 10 minutes and preincubated for 20 minutes at 37°C. The slides were denatured separately at 80°C for four minutes. Hybridisation was overnight at 37°C in a humidified chamber. Analysis of 125 interphase nuclei from the proband, his father, and a normal control was performed by counting the hybridisation signals per nucleus. Blood samples were not available from other members of the family. 
Results
CLINICAL REPORT
The proband developed distal lower limb weakness at 10 years, and at the age of 19 required a right ankle arthrodesis. He noted some diminution in sensation in the feet but denied weakness or sensory loss in the upper limbs. He had a significant degree of bilateral sensorineural deafness. On examination his speech was slightly dysarthric and apart from his deafness his cranial nerves were normal. In the limbs there was no tremor, he had mild bilateral weakness of the intrinsic muscles of the hands, and marked weakness of ankle dorsiflexion. The ankle jerks were absent but knee jerks and all upper limb tendon reflexes were normal. Sensory loss was most marked in the feet and he had a painless ulcer over the head of the first left metatarsal. He had bilateral pes planus, clawing of the toes, and palpable enlargement of the common peroneal nerves. Electrophysiologically, the median motor nerve conduction velocity was 33 m/second, the median sensory action potential (MSAP) was 5 ,uV, and the ulnar sensory action potential (USAP) was 2,V. His lateral popliteal motor conduction could not be measured as extensor digitorum brevis was denervated. His father had clawing of the toes from childhood and had been noted to be clumsy. However, he was aware of increasing unsteadiness of gait from the age of 40 and some difficulty with coordination in the upper limbs from the age of 50. Neurological examination did not show any weakness in the lower limbs and all his tendon reflexes were intact. He had minimal sensory impairment in the feet, and had bilateral pes planus. Electrophysiological examination showed a normal median motor conduction velocity (54 m/second), a mild drop of the ulnar conduction velocity (46 m/second), and a significant slow sural sensory nerve conduction velocity (22 m/second). His ulnar sensory action potential was absent, and his median sensory action potential was 6 ,uV. The possibility of undetected mosaicism has been suggested in a CMT1 family.'6 Mosaicism for deletion within this region of chromosome 17 has been previously reported. '5 In this family, the mildly affected mother of a proband with Smith-Magenis syndrome associated with a visible deletion of I 7p 1 .2-p 12 was also found to have the deletion in 55% of cells examined. Our findings show the potential importance of using FISH as a first line diagnostic test for CMT1A, and at present the technique would appear to be the only way of detecting mosaicism in the disease. The result also raises the issue of whether parents of sporadic CMT1A cases should be tested by FISH to exclude the possiblity of mosaicism.
